Gary A. Zarkin, PhD, is a Distinguished Fellow in the Community Health Research Division. Dr. Zarkin has published extensively on the cost, cost-effectiveness, and the benefit-cost of substance abuse interventions. He was a contributing author on Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health.
Dr. Zarkin is currently one of the multiple principal investigators on RTI’s Data Coordinating Center for the NIDA-funded HEALing Communities Study that is estimating the effectiveness and cost-effectiveness of expanding naloxone distribution and medication-based treatment in select communities hard hit by the opioid crisis. He is also working on the cost and cost-effectiveness component of the SOMATICS collaborative study funded by the National Institute on Drug Abuse (NIDA) that studies pharmacotherapy for opioid treatment in criminal justice settings. Dr. Zarkin was the Principal Investigator (PI) on a multi-site National Institute on Alcohol Abuse and Alcoholism (NIAAA) grant estimating the cost and cost-effectiveness of nine alternative medication and behavioral alcohol treatments in the Combining Medications and Behavioral Interventions for Alcoholism (COMBINE) study.
